Abstract
1. Human platelet-rich plasma was incubated at 37 degrees C with [8-14C]ADP and with human serum albumin labelled with 125I. The platelets were rapidly separated by centrifugation through silicone oil. From radioactivity determinations of plasma and platelet pellets the uptake of ADP, without or with break-down products, by the platelets was calculated on the assumption that the 125I radioactivity in the pellet represented trapped plasma. 2. ADP radioactivity was taken up by platelets within 10 sec and increased with time of incubation. The uptake of other nucleotide diphosphates was less initially and increased much more slowly. 3. Radioactivity added as ADP was recovered as ATP to the extent of 60%; as ADP of 30%; and as AMP of 10%. 4. Prostaglandin E1 which inhibited platelet aggregation had no effect on the initial or subsequent uptake or on this distribution of radioactivity. 5. The rate of rise in uptake was much slower when platelets were resuspended in plasma heated to 56 degrees C for 30 min. 6. Unlabelled adenosine inhibited the later, but not the initial, uptake while unlabelled ADP inhibited both. Dipyridamole, which blocks adenosine uptake, prevented the later but not the initial uptake. 7. [alpha-32P]ADP radioactivity was taken up at the earliest sampling time and the extent of uptake did not further increase. 8. Guinea-pig platelets, which do not take up adenosine, took up [8-14C]ADP radioactivity from purine-labelled ADP initially. 9. It was concluded that the initial uptake represented binding of ADP and that the later uptake represented labelled adenosine originating as a break-down product of ADP. 10. A Scatchard plot of ADP uptake indicated more than one type of binding site. There were approximately 88,000 high affinity sites per platelet which had an affinity constant of 5-41 X 10(5) M-1.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BORN G. V. STRONG INHIBITION BY 2-CHLOROADENOSINE OF THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE. Nature. 1964 Apr 4;202:95–96. doi: 10.1038/202095b0. [DOI] [PubMed] [Google Scholar]
- Born G. V., Hume M. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature. 1967 Sep 2;215(5105):1027–1029. doi: 10.1038/2151027a0. [DOI] [PubMed] [Google Scholar]
- Born G. V. Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol. 1970 Aug;209(2):487–511. doi: 10.1113/jphysiol.1970.sp009176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Born G. V. Uptake of adenosine and of adenosine diphosphate by human blood platelets. Nature. 1965 Jun 12;206(989):1121–1122. doi: 10.1038/2061121a0. [DOI] [PubMed] [Google Scholar]
- Boullin D. J., Green A. R., Price K. S. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 . J Physiol. 1972 Mar;221(2):415–426. doi: 10.1113/jphysiol.1972.sp009758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burgen A. S. The drug-receptor complex. J Pharm Pharmacol. 1966 Mar;18(3):137–149. doi: 10.1111/j.2042-7158.1966.tb07840.x. [DOI] [PubMed] [Google Scholar]
- GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
- Gough G., Maguire M. H., Penglis F. Analogues of adenosine 5'-diphosphate-new platelet aggregators. Influence of purine ring and and phosphate chain substitutions on the platelet-aggregating potency of adenosine 5'-diphosphate. Mol Pharmacol. 1972 Mar;8(2):170–177. [PubMed] [Google Scholar]
- Haslam R. J., Mills D. C. The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma. Biochem J. 1967 Jun;103(3):773–784. doi: 10.1042/bj1030773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmsen H., Rozenberg M. C. Adenine nucleotide metabolism of blood platelets. I. Adenosine kinase and nucleotide formation from exogenous adenosine and AMP. Biochim Biophys Acta. 1968 Feb 26;155(2):326–341. [PubMed] [Google Scholar]
- Klotz I. M. Physiochemical aspects of drug-protein interactions: a general perspective. Ann N Y Acad Sci. 1973 Nov 26;226:18–35. doi: 10.1111/j.1749-6632.1973.tb20465.x. [DOI] [PubMed] [Google Scholar]
- MACMILLAN D. C., OLIVER M. F. THE INITIAL CHANGES IN PLATELET MORPHOLOGY FOLLOWING THE ADDITION OF ADENOSINE DIPHOSPHATE. J Atheroscler Res. 1965 Jul-Aug;5(4):440–444. doi: 10.1016/s0368-1319(65)80081-3. [DOI] [PubMed] [Google Scholar]
- Maguire M. H., Michal F. Powerful new aggregator of blood platelets--2-chloroadenosine-5'-diphosphate. Nature. 1968 Feb 10;217(5128):571–573. doi: 10.1038/217571a0. [DOI] [PubMed] [Google Scholar]
- Nachman R. L., Ferris B. Binding of adenosine diphosphate by isolated membranes from human platelets. J Biol Chem. 1974 Feb 10;249(3):704–710. [PubMed] [Google Scholar]
- Salzman E. W., Ashford T. P., Chambers D. A., Neri L. L. Platelet incorporation of labelled adenosine and adenosine diphosphate. Thromb Diath Haemorrh. 1969 Nov 15;22(2):304–315. [PubMed] [Google Scholar]
- Salzman E. W., Chambers D. A., Neri L. L. Incorporation of labelled nucleotides and aggregation of human blood platelets. Thromb Diath Haemorrh. 1966 Jan 31;15(1):52–68. [PubMed] [Google Scholar]
- Spaet T. H., Lejnieks I. Studies on the mechanism whereby platelets are clumped by adenosine diphosphate. Thromb Diath Haemorrh. 1966 Jan 31;15(1):36–51. [PubMed] [Google Scholar]